ABBEY MORREN: Open Payments
NPI 1831749159 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,244 in 49 payments from 12 companies in 2025. Trend: 2023 $24 · 2024 $303 · 2025 $1,244
Food & beverage: $1,144Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $425 |
| Incyte Corporation | 8 | $314 |
| ABBVIE INC. | 15 | $220 |
| Novartis Pharmaceuticals Corporation | 3 | $60 |
| Biofrontera Inc. | 2 | $44 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $39 |
| Regeneron Healthcare Solutions, Inc. | 2 | $39 |
| UCB, Inc. | 1 | $35 |
| Arcutis Biotherapeutics, Inc. | 1 | $19 |
| LEO Pharma Inc. | 1 | $18 |
Products named: TREMFYA, OPZELURA, RINVOQ, DUPIXENT, ILUMYA, COSENTYX, Bimzelx, SKYRIZI.
Industry payments across CA — which companies pay providers there.
